- Home
- ARQT vs SKE Comparison
ARQT vs SKE Comparison
Compare ARQT & SKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQT
- SKE
- Stock Information
- Founded
- ARQT 2016
- SKE 1979
- Country
- ARQT United States
- SKE Canada
- Employees
- ARQT N/A
- SKE N/A
- Industry
- ARQT Biotechnology: Pharmaceutical Preparations
- SKE Precious Metals
- Sector
- ARQT Health Care
- SKE Basic Materials
- Exchange
- ARQT Nasdaq
- SKE Nasdaq
- Market Cap
- ARQT 1.1B
- SKE 993.1M
- IPO Year
- ARQT 2020
- SKE N/A
- Fundamental
- Price
- ARQT $14.99
- SKE $9.06
- Analyst Decision
- ARQT Strong Buy
- SKE
- Analyst Count
- ARQT 4
- SKE 0
- Target Price
- ARQT $15.50
- SKE N/A
- AVG Volume (30 Days)
- ARQT 2.2M
- SKE 342.3K
- Earning Date
- ARQT 11-06-2024
- SKE 11-14-2024
- Dividend Yield
- ARQT N/A
- SKE N/A
- EPS Growth
- ARQT N/A
- SKE N/A
- EPS
- ARQT N/A
- SKE N/A
- Revenue
- ARQT $138,708,000.00
- SKE N/A
- Revenue This Year
- ARQT $208.32
- SKE N/A
- Revenue Next Year
- ARQT $48.56
- SKE $50.00
- P/E Ratio
- ARQT N/A
- SKE N/A
- Revenue Growth
- ARQT 182.84
- SKE N/A
- 52 Week Low
- ARQT $2.60
- SKE $3.29
- 52 Week High
- ARQT $15.77
- SKE $10.33
- Technical
- Relative Strength Index (RSI)
- ARQT 67.53
- SKE 48.68
- Support Level
- ARQT $12.66
- SKE $8.70
- Resistance Level
- ARQT $15.02
- SKE $9.60
- Average True Range (ATR)
- ARQT 1.11
- SKE 0.38
- MACD
- ARQT 0.14
- SKE -0.04
- Stochastic Oscillator
- ARQT 78.92
- SKE 36.55
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate ZORYVE roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
About SKE Skeena Resources Limited
Skeena Resources Ltd is a Canadian mining exploration company focused on developing prospective precious and base metal properties in the Golden Triangle of northwest British Columbia, Canada. The company's primary activity is the exploration and development of the past-producing Eskay Creek mine acquired from Barrick.